 Foresite Capital Management IV LLC lessened its position in shares of Fulcrum Therapeutics NASDAQ:FULC by 33.4 during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 998,655 shares of the companys stock after selling 501,345 shares during the quarter. Fulcrum Therapeutics makes up 14.3 of Foresite ... 